captopril has been researched along with Lupus Nephritis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, DE; Boivin, GP; Brunner, HI; De Albuquerque, DA; Saxena, V; Singh, RR; Witte, DP | 1 |
| Daza, L; Flores, J; Kornhauser, C; Zamora, L | 1 |
| Gerasimenko, OI; Kutyrina, IM; Shvetsov, MIu; Tareeva, IE | 1 |
| García-Porrúa, C; González-Gay, MA; López Lázaro, L; Olivé, A | 1 |
| Bagirova, VV; Bugrova, OV; Gromova, MM; Kutyrina, IM; Morozova, EV | 1 |
| Friedler, A; Mor, F; Shapira, Y; Weinberger, A; Wysenbeek, AJ | 1 |
| Herlitz, H; Svalander, C; Tarkowski, A; Westberg, G | 1 |
| Herlitz, H; Svalander, C; Tarkowski, A; Volkmann, R; Westberg, G | 1 |
2 trial(s) available for captopril and Lupus Nephritis
| Article | Year |
|---|---|
Captopril effect on prostaglandin E2, thromboxane B2 and proteinuria in lupus nephritis patients.
Topics: Adolescent; Adult; Captopril; Cyclophosphamide; Dinoprostone; Humans; Lupus Nephritis; Prednisolone; Proteinuria; Thromboxane B2 | 2005 |
[Hemodynamic mechanisms of lupus nephritis progression].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Female; Hemodynamics; Humans; Hypertension, Renal; Kidney; Kidney Function Tests; Lupus Nephritis; Male; Prognosis; Ramipril | 1998 |
6 other study(ies) available for captopril and Lupus Nephritis
| Article | Year |
|---|---|
An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoantibodies; Captopril; Chronic Disease; Cytokines; Gene Expression; Interleukin-10; Interleukin-4; Kidney; Lupus Nephritis; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Mice, Inbred NZB; RNA, Messenger; Spleen; Th2 Cells; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2 | 2004 |
Successful response to captopril in severe nephrotic syndrome secondary to lupus nephritis.
Topics: Adolescent; Captopril; Female; Humans; Lupus Nephritis; Nephrotic Syndrome | 1998 |
[Effects of acute pharmacological blockade of the renin-angiotensin system on intrarenal hemodynamics in patients with systemic lupus erythematosus and systemic scleroderma].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Female; Hemodynamics; Humans; Kidney; Lupus Nephritis; Male; Middle Aged; Renin-Angiotensin System; Scleroderma, Systemic; Software; Ultrasonography, Doppler, Duplex | 2001 |
Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome.
Topics: Adult; Atenolol; Body Weight; Captopril; Creatinine; Female; Furosemide; Humans; Hypertension; Lupus Nephritis; Nephrotic Syndrome; Proteinuria; Time Factors | 1990 |
Influence of antihypertensive treatment on renal and extrarenal lupus manifestations in MRL/l mice.
Topics: Animals; Blood Pressure; Bretylium Compounds; Captopril; Enalapril; Female; Hypertension; Lupus Nephritis; Mice; Mice, Inbred Strains | 1988 |
Beneficial effect of captopril on systemic lupus erythematosus-like disease in MRL lpr/lpr mice.
Topics: Animals; Blood Pressure; Bretylium Compounds; Captopril; Cyclophosphamide; Dermatitis; Female; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred Strains; Mice, Mutant Strains | 1988 |